World's Best Scientists 2026 revealed!
Yoshimichi Okayama

Yoshimichi Okayama

D-Index & Metrics

Immunology

D-Index
51
Citations
9883
World Ranking
4144
National Ranking
159

Yoshimichi Okayama publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Yoshimichi Okayama sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 192 publications — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Yoshimichi Okayama D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Yoshimichi Okayama sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 51 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Yoshimichi Okayama is affiliated with Nihon University in Japan. Their research primarily addresses topics in medicine, with a significant focus on immunology and microbiology. Within these domains, they explore subfields such as immunology, rheumatology, immunology and allergy, physiology, and genetics.

Their scientific work covers various specialized topics including:

  • Mast cells and histamine
  • Urticaria and related conditions
  • IL-33, ST2, and ILC pathways
  • Asthma and respiratory diseases
  • Food allergy and anaphylaxis research
  • Coagulation, bradykinin, polyphosphates, and angioedema
  • Allergic rhinitis and sensitization

Yoshimichi Okayama has published extensively, contributing to prominent journals with a focus on allergic and immunological research. Frequent publication venues for their work include:

  • Allergology International
  • Journal of Allergy and Clinical Immunology
  • Allergy
  • Asia Pacific Allergy
  • Modern Rheumatology

Key recent papers authored or coauthored by Yoshimichi Okayama are:

  • Roles of omalizumab in various allergic diseases, 2020, Allergology International
  • Activation of inflammation and resolution pathways of lipid mediators in synovial fluid from patients with severe rheumatoid arthritis compared with severe osteoarthritis, 2020, Asia Pacific Allergy
  • Orally desensitized mast cells form a regulatory network with Treg cells for the control of food allergy, 2020, Mucosal Immunology
  • miR103a-3p in extracellular vesicles from FcεRI-aggregated human mast cells enhances IL-5 production by group 2 innate lymphoid cells, 2021, Journal of Allergy and Clinical Immunology
  • Neuro-allergology: Mast cell-nerve cross-talk, 2022, Allergology International

The scientist frequently collaborates with a group of recurring coauthors. These include:

  • Shota Toyoshima
  • Koremasa Hayama
  • Tadashi Terui
  • Yusuke Kurosawa
  • Yasuhiro Gon

Best Publications

  • Interleukin 4 is localized to and released by human mast cells

    P Bradding;I H Feather;P H Howarth;R Mueller

  • Development, migration, and survival of mast cells.

    Yoshimichi Okayama;Toshiaki Kawakami

  • IL-33 can promote survival, adhesion and cytokine production in human mast cells.

    Motoyasu Iikura;Hajime Suto;Hajime Suto;Naoki Kajiwara;Keisuke Oboki

  • Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria

    Daisuke Fujisawa;Jun Ichi Kashiwakura;Hirohito Kita;Yusuke Kikukawa

  • Heterogeneity of human mast cells based on cytokine content.

    P Bradding;Y Okayama;P H Howarth;M K Church

  • IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcεRI signals

    Lien H. Ho;Tatsukuni Ohno;Keisuke Oboki;Naoki Kajiwara

  • Oxidative Stress in Allergic and Inflammatory Skin Diseases

    Yoshimichi Okayama

  • Expression of a functional high-affinity IgG receptor, Fc gamma RI, on human mast cells: Up-regulation by IFN-gamma.

    Yoshimichi Okayama;Arnold S. Kirshenbaum;Dean D. Metcalfe

  • T Cell Proliferation by Direct Cross-Talk between OX40 Ligand on Human Mast Cells and OX40 on Human T Cells: Comparison of Gene Expression Profiles between Human Tonsillar and Lung-Cultured Mast Cells

    Jun-ichi Kashiwakura;Hidenori Yokoi;Hirohisa Saito;Yoshimichi Okayama

  • Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis

    Makiko Shimizu;Akira Matsuda;Ken Yanagisawa;Tomomitsu Hirota

  • IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells.

    Y Okayama;C Petit-Frére;O Kassel;A Semper

  • NF-κB and TNF-α: A Positive Autocrine Loop in Human Lung Mast Cells?

    William R. Coward;Yoshimichi Okayama;Hironori Sagara;Susan J. Wilson

  • FcεRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells

    Shigeru Okumura;Hironori Sagara;Takeshi Fukuda;Hirohisa Saito

  • Tissue remodeling induced by hypersecreted epidermal growth factor and amphiregulin in the airway after an acute asthma attack

    Yukinori Enomoto;Kanami Orihara;Tetsuya Takamasu;Akio Matsuda

  • Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases

    Dean D. Metcalfe;Ruby Pawankar;Steven J. Ackerman;Cem Akin

  • Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcepsilonRI.

    Unknown

  • Activation of human mast cells through the platelet-activating factor receptor

    Naoki Kajiwara;Tomomi Sasaki;Peter Bradding;Glenn Cruse

  • Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine

    Y. Okayama;R. C. Benyon;P. H. Rees;M. A. Lowman

  • A comparison of mediators released or generated by IFN-gamma-treated human mast cells following aggregation of Fc gamma RI or Fc epsilon RI.

    Yoshimichi Okayama;David D. Hagaman;Dean D. Metcalfe

  • Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2–DP1 receptor paracrine axis

    Yoshitaka Taketomi;Yoshitaka Taketomi;Noriko Ueno;Takumi Kojima;Hiroyasu Sato;Hiroyasu Sato

  • FcεRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells

    Y. Okayama;S. Okumura;H. Sagara;K. Yuki

Frequent Co-Authors

Hirohisa Saito
Hirohisa Saito Juntendo University
Chisei Ra
Chisei Ra Nihon University
Martin K. Church
Martin K. Church Southampton General Hospital
Akira Matsuda
Akira Matsuda Juntendo University
Kenji Matsumoto
Kenji Matsumoto Izumi Municipal Hospital
Hirokazu Kimura
Hirokazu Kimura RMIT University
Dean D. Metcalfe
Dean D. Metcalfe National Institute of Allergy and Infectious Diseases
Chisei Ra
Chisei Ra Juntendo University
Masatomo Mori
Masatomo Mori Gunma University
Makoto Murakami
Makoto Murakami University of Tokyo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can provide valuable career opportunities. One popular route is becoming a Nurse Practitioner (NP), where advanced clinical skills complement immunological knowledge. Those looking for flexible, cost-effective options should explore the cheapest pmhnp programs online, which offer specialized training in psychiatric mental health.

Nurses aiming to enhance their expertise might consider accelerated paths. Accelerated NP programs enable faster completion, making it easier to transition into roles that intersect with Immunology, such as acute care.

Speaking of acute care, certification is essential for those who want to work in high-intensity environments. Programs on acute care np certification guide practitioners through this critical transition, opening doors to specialties closely related to Immunology management.

Finally, salary potential varies widely across NP specialties. Checking out data on the highest paid dnp specialties can help students and professionals select a career pathway that is both rewarding and aligned with their passion for Immunology.

Best Scientists Citing Yoshimichi Okayama

Trending Scientists